| Type | Period | Ended | Filed | |
|---|---|---|---|---|
| 10-K | FY 2025 | 12/31/25 | 2/12/26 | → |
| 10-Q | Q3 2025 | 9/30/25 | 11/4/25 | → |
| 10-Q | Q2 2025 | 6/30/25 | 8/5/25 | → |
| 10-Q | Q1 2025 | 3/31/25 | 5/1/25 | → |
| 10-K | FY 2024 | 12/31/24 | 2/12/25 | → |
| 10-Q | Q3 2024 | 9/30/24 | 10/30/24 | → |
| ↓ | ||||
| Filed | Period | |
|---|---|---|
| 2/12/26 | Q1 FY2026 | → |
| 11/4/25 | Q4 FY2025 | → |
| 8/5/25 | Q3 FY2025 | → |
| 5/1/25 | Q2 FY2025 | → |
| 2/12/25 | Q1 FY2025 | → |
| 10/30/24 | Q3 FY2024 | → |
| ↓ | ||
| Filed | Type | Description | |
|---|---|---|---|
| 1/8/26 | Agreement | Entry into a Material Definitive Agreement | → |
| 1/2/26 | Agreement | Entry into a Material Definitive Agreement | → |
| 6/17/25 | Vote | Submission of Matters to a Vote of Security Holders | → |
| 3/3/25 | Exec Change | Departure or Appointment of Directors or Certain Officers | → |
| 1/10/25 | Acquisition | Entry into a Material Definitive Agreement | → |
| 12/18/24 | Exec Change | Departure or Appointment of Directors or Certain Officers | → |
| ↓ | |||
| Filed | Form | Description | |
|---|---|---|---|
| 3/4/26 | S-8 | S-8 | → |
| 4/23/25 | ARS | ARS | → |
| 2/28/25 | S-8 | S-8 | → |
| 11/4/24 | S-8 | S-8 | → |
| 4/26/24 | ARS | ARS | → |
| 2/16/24 | S-8 | S-8 | → |
| ↓ | |||
| Filed | Form | Description | |
|---|---|---|---|
| 4/23/25 | DEFA14A | DEFA14A | → |
| 4/23/25 | DEF 14A | DEF 14A | → |
| 4/26/24 | DEFA14A | DEFA14A | → |
| 4/26/24 | DEF 14A | DEF 14A | → |
| 4/16/24 | PRE 14A | PRE 14A | → |
| 4/28/23 | DEFA14A | DEFA14A | → |
| ↓ | |||
| Filed | Form | Description | |
|---|---|---|---|
| 3/6/26 | 4 | 4 | → |
| 3/6/26 | 4 | 4 | → |
| 3/6/26 | 4 | 4 | → |
| 3/6/26 | 4 | 4 | → |
| 3/3/26 | 4 | 4 | → |
| 3/3/26 | 4 | 4 | → |
| ↓ | |||
| Filed | Form | Description | |
|---|---|---|---|
| 3/2/26 | 144 | 144 | → |
| 3/2/26 | 144 | 144 | → |
| 3/2/26 | 144 | 144 | → |
| 2/13/26 | SCHEDULE 13G/A | SCHEDULE 13G/A | → |
| 2/12/26 | SCHEDULE 13G/A | SCHEDULE 13G/A | → |
| 1/26/26 | SCHEDULE 13G | SCHEDULE 13G | → |
| ↓ | |||
American Well Corporation, doing business as Amwell, is a telemedicine company based in Boston, Massachusetts, that connects patients with doctors over secure video. Amwell sells its platform as a subscription service to healthcare providers to put their medical professionals online and its proprietary software development kits, APIs, and system integrations enable clients to embed telehealth into existing workflows utilized by providers and patients.